Observational Study of Patient with frequent COPD Exacerbations - CERERA

Study identifier:D5980R00123

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Clinical and dEmographic chaRacteristics of patients with frequent COPD Exacerbations and evaluation of therapeutic approaches in treatment in RussiA

Medical condition

Chronic obstructive pulmonary disease (COPD)

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

2000

Study type

Observational

Age

18 Years - 100 Years

Date

Study Start Date: 16 Dec 2024
Estimated Primary Completion Date: 30 Jun 2026
Estimated Study Completion Date: 30 Jun 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2025 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria